Harvis Pharm

Hyderabad, India Founded: 2003 • Age: 23 yrs
Supplies APIs, ingredients, and finished dosage forms for generic pharmaceuticals globally.

About Harvis Pharm

Harvis Pharm is a Healthcare company based in Hyderabad (India) founded in 2003. It supplies APIs, ingredients, and finished dosage forms for generic pharmaceuticals globally. It operates on a B2B model. Harvis Pharm offers products and services including APIs, Ingredients, and Finished Dosage Forms. Its focus areas include Pharmaceuticals, Generic Drugs, API Manufacturing and Finished Dosage Forms. Its legal entity is Harvis Pharm LLP. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.

Company details

Harvis Pharm LLP serves the generic pharmaceutical industry by providing APIs for international markets, ingredients in India, and finished dosage forms. As an outsourcing partner, they focus on high-quality, safe, and affordable medicines through sourcing solutions. Based in Hyderabad, India, with operations in Italy, they enable manufacturers to access global customers and build business performance.

  • Headquarters Hyderabad, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website harvispharm.com
  • Legal Name Harvis Pharm Llp

Products & Services of Harvis Pharm

Harvis Pharm offers a comprehensive portfolio of products and services, including APIs, Ingredients, and Finished Dosage Forms.

APIs
Active Pharmaceutical Ingredients

International supply of active ingredients for generic drugs manufacturing

Ingredients
Raw Materials

Sourcing of pharmaceutical ingredients specifically in India

Finished Dosage Forms
Pharmaceutical Products

Production and supply of ready-to-use generic formulations

Board of directors of Harvis Pharm

The boards of the 2 registered companies of Harvis Pharm currently have 2 directors; the longest-serving is Vishaka Kalakata, appointed in 2023. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vishaka Kalakata
DIN 08791537
Designated Partner23 Jan 20233 yrs 8 moHarvis Pharma Integral Solutions Llp, Harvis Pharm Private Limited
Srinivas Venkat Yellai
DIN 00487853
Designated Partner23 Jan 20233 yrs 8 moHarvis Pharma Integral Solutions Llp, Harvis Pharm Private Limited

Financials of Harvis Pharm

Figures of Harvis Pharm Private Limited, the primary company behind Harvis Pharm, for FY 2022. Revenue was ₹1.7 Lakh (-58% year on year). Net loss was -₹9.6 Lakh (-547% margin). EBITDA was -₹9.6 Lakh (-547% margin). Revenue has grown at a compounded annual rate of -62% over three years and -43% over five years.

  • ₹1.7 LakhRevenue · FY 2022 · -58% YoY
  • -₹9.6 LakhNet loss · -547% margin
  • -₹9.6 LakhEBITDA · -547% margin
  • ₹1 LakhPaid-up capital
  • -62%Revenue CAGR, 3 years
  • -43%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Harvis Pharm Private Limited are on its company page.

Premium access

Detailed financial statements for Harvis Pharm

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Harvis Pharm

Harvis Pharm has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
provepharm.com1998Marseille, France$145.93M–
APIs and drug products are developed and valorized in pharmaceuticals.
biostar-pharm.com2002Beijing, China$135.23M–
APIs, intermediates, and biochemical reagents are developed and manufactured.
sequent.in2002Bengaluru, India––
APIs are developed and manufactured for therapeutic areas.
sterlingpharmasolutions.com2016Dudley, United Kingdom–560
Contract development, manufacturing, and analytical services for APIs are offered.
snapdragonchemistry.com2014Cambridge, United States–43
Drug discovery and development service provider
jubilantpharma.com1978Noida, India––
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
hikal.com1988Mumbai, India–355
APIs and intermediates are produced via custom synthesis and research.
Premium access

Detailed similar companies of Harvis Pharm

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Harvis Pharm (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Harvis Pharm

Harvis Pharm was founded in 2003.

Harvis Pharm is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Harvis Pharm LLP serves the generic pharmaceutical industry by providing APIs for international markets, ingredients in India, and finished dosage forms. As an outsourcing partner, they focus on high-quality, safe, and affordable medicines through sourcing solutions. Based in Hyderabad, India, with operations in Italy, they enable manufacturers to access global customers and build business performance.

Harvis Pharm's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Harvis Pharm offers APIs, Ingredients, and Finished Dosage Forms.

Harvis Pharm is associated with 2 legal entities: Harvis Pharma Integral Solutions Llp, Harvis Pharm Private Limited.

The legal entities of Harvis Pharm currently have 2 directors, including Vishaka Kalakata, Srinivas Venkat Yellai.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available